Valeant becomes Bausch Health Companies

Valeant Pharmaceuticals, the Canadian-based company that took over Bausch + Lomb five years ago with a total investment of $8.3 billion, will change its name next month to Bausch Health Companies, with a new corporate brand identity, new imagery, a new website and a new stock market ticker, BHC.

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.